logo
Share SHARE
FONT-SIZE Plus   Neg

Court Rules In Favor Of Boston Scientific In Johnson & Johnson Litigation

Medical device maker Boston Scientific Corp. (BSX) announced that the U.S. District Court for the District of New Jersey has found all the asserted patents in a suit brought by Healthcare giant Johnson & Johnson (JNJ) to be invalid and entered judgment in favor of Boston Scientific.

Under the 2008 patent infringement suit, Johnson & Johnson alleged that Boston Scientific's PROMUS Everolimus-Eluting Coronary Stent System infringed two patents, U.S. Patent Nos. 5,516,781 and 5,563,146. The patents relate to the use of a drug on a drug-eluting stent.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Social networking giant Facebook, Inc. said Wednesday after the markets closed that its second quarter profit fell 9% from last year, as higher costs and expenses more than offset a 39% increase in revenue. However, the company's quarterly earnings per share, excluding items, came in above analysts' expectations as did its quarterly revenue. Western Digital Corp. (WDC) on Wednesday reported a drop in profit for the fourth quarter as revenues continued to decline due to a weak PC market. Nevertheless, shares of the hard disk drive maker rose 5 percent after its fourth-quarter profit topped analysts' estimates. Irvine, California-based... Microsoft is reportedly working on streaming PC games to Xbox One consoles as the software giant strives to generate demand for both.
comments powered by Disqus
Follow RTT